In Massachusetts, GenePeeks, Inc. has a new President and Chief Commercial Officer, Matt Posard, who comes with over 25 years of experience at a variety of genomic and life sciences companies including Illumina, Inc., Trovagene, Inc. and Alere, Inc. His role at GenePeeks will be to head up commercialization of their computational genomics products and services. Their patented Virtual Progeny Analytics product takes the genetic makeup of two parents and computationally predicts what diseases or health issues their child will be at risk for, genetically speaking, before they even conceive a baby. Many parents want to know the risks before they conceive, especially for serious diseases, so they can be more prepared for the possibilities.
Latest article
Snack rats eat biobased fiber optic cables, send London’s G.Network into bankruptcy
In the United Kingdom, London internet provider G.Network has entered administration because it used fiber optic cable jackets made of soy- and corn-based materials...
Samsung creates e-paper with phytoplankton display
In South Korea, Samsung Electronics has unveiled an e-paper with a display made of phytoplankton-based plastics.
E‑paper is a display technology that replicates the...
Make Good launches mushroom-based shoes
In Australia, shoe brand Make Good has created a Derby shoe style with a variety of biobased materials. Dubbed Derby V1, the shoe includes...